Arthrosi Therapeutics, Inc., a clinical-stage biotechnology company, announced the completion of enrollment for its global Phase 2b clinical study of AR882 for the treatment...
Roche announced CE label expansion of the VENTANA PD-L1 (SP263) Assay in non-small cell lung cancer (NSCLC) as a companion diagnostic for Tecentriq® (atezolizumab)....
Avenge Bio, Inc., a biotechnology company developing the LOCOcyte immunotherapy platform for the precision administration of potent immune effector molecules to treat solid tumors, ...
EpiVario, Inc., an emerging biotech company developing novel therapeutics for memory-related psychiatric disorders, highlighted preclinical research findings that could lead to a treatment approach...
Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced that the...
